-
Researchers from Japan have completed a Cochrane review which explores whether proton pump inhibitors (PPIs) are effective in (a) reducing chronic obstructive pulmonary disease (COPD) exacerbations, and (b) improving quality of life for people with COPD.The team found only one study, with 103 participants. This study showed that giving PPIs to...
August 25 2020
-
This overview of Cochrane Review of interventions for escalation of therapy for acute exacerbations of asthma in children provides the most up-to-date information to people making decisions about healthcare.For children with acute severe asthma requiring additional treatment, the review found that:Intravenous magnesium sulfate (a bronchodilator...
August 5 2020
-
Today we launch a report on our 'whole-of-scope' priority-setting work. One hundred uncertainties submitted by the public were ranked by a group of stakeholders - the Cochrane AIrways Priority-setting group (CAPSG). The top uncertainties were interventions to prevent asthma deaths, evidence mapping exercise for COPD, and interventions to help...
May 6 2020
-
Clinical trials are used to determine whether an intervention (treatment) is safe and effective compared to another intervention. Safety and efficacy are evaluated by measuring a range of outcomes (such as measures of quality of life, admission to hospital, or lung function). Clinical trials evaluating interventions for the management of chronic...
May 5 2020
-
Phillippa Poole from the University of Auckland and colleagues from Cochrane Airways editorial team at St George’s University of London have updated the Cochrane Review: Phosphodiesterase-4 inhibitors for Chronic obstructive pulmonary disease (COPD).The team added a total of five new studies from the search run in March 2020. The studies...
May 4 2020
-
We have gathered together a selection of links to information and resources related to COVID-19 from the respiratory and evidence syntheses communities, including guidelines, rapid reviews and 'living' evidence syntheses, primary study registers and search strategy resources.Respiratory societiesATS COVID-19 Resource Center (American Thoracic...
April 7 2020
-
Dear colleagues We recognise that these are uncertain times and the impact of the COVID-19 pandemic will be felt by many of you. We want to reassure you that your health, and your current priorities at work and home, are of the utmost importance to us. For those of you with any ongoing or pending tasks relating to a Cochrane Airways Review or...
April 1 2020
-
We have curated this Special Collection for people who live with COPD, for those caring for people with COPD, and for healthcare professionals. The Collection brings together a series of Cochrane Reviews addressing COPD, aligned with the theme of World COPD Day 2019: ‘All together to end COPD’. The reviews have been selected to address COPD care...
November 19 2019
-
The Airways team is delighted to introduce some new additions to our Editorial Board. Editors comment on most protocols and the interpretation and methods in most reviews. Our new Associate Editors are:Hayley Barnes, Alfred Hospital, Melbourne, AustraliaHayley is a respiratory physician based in Melbourne, Australia, and she specialises in...
November 15 2019
-
Cochrane Airways es un grupo que trabaja en todo el mundo para publicar revisiones sistemáticas Cochrane sobre la prevención y el tratamiento de enfermedades respiratorias (pulmonares). Estos incluyen asma, EPOC (enfermedad pulmonar obstructiva crónica), apnea obstructiva del sueño, bronquiectasia, enfermedad pulmonar intersticial, fibrosis...
August 28 2019
Researchers from Japan have completed a Cochrane review which explores whether proton pump inhibitors (PPIs) are effective in (a) reducing chronic obstructive pulmonary disease (COPD) exacerbations, and (b) improving quality of life for people with COPD.The team found only one study, with 103 participants. This study showed that giving PPIs to...August 25 2020
This overview of Cochrane Review of interventions for escalation of therapy for acute exacerbations of asthma in children provides the most up-to-date information to people making decisions about healthcare.For children with acute severe asthma requiring additional treatment, the review found that:Intravenous magnesium sulfate (a bronchodilator...August 5 2020
Today we launch a report on our 'whole-of-scope' priority-setting work. One hundred uncertainties submitted by the public were ranked by a group of stakeholders - the Cochrane AIrways Priority-setting group (CAPSG). The top uncertainties were interventions to prevent asthma deaths, evidence mapping exercise for COPD, and interventions to help...May 6 2020
Clinical trials are used to determine whether an intervention (treatment) is safe and effective compared to another intervention. Safety and efficacy are evaluated by measuring a range of outcomes (such as measures of quality of life, admission to hospital, or lung function). Clinical trials evaluating interventions for the management of chronic...May 5 2020
Phillippa Poole from the University of Auckland and colleagues from Cochrane Airways editorial team at St George’s University of London have updated the Cochrane Review: Phosphodiesterase-4 inhibitors for Chronic obstructive pulmonary disease (COPD).The team added a total of five new studies from the search run in March 2020. The studies...May 4 2020
We have gathered together a selection of links to information and resources related to COVID-19 from the respiratory and evidence syntheses communities, including guidelines, rapid reviews and 'living' evidence syntheses, primary study registers and search strategy resources.Respiratory societiesATS COVID-19 Resource Center (American Thoracic...April 7 2020
Dear colleagues We recognise that these are uncertain times and the impact of the COVID-19 pandemic will be felt by many of you. We want to reassure you that your health, and your current priorities at work and home, are of the utmost importance to us. For those of you with any ongoing or pending tasks relating to a Cochrane Airways Review or...April 1 2020
We have curated this Special Collection for people who live with COPD, for those caring for people with COPD, and for healthcare professionals. The Collection brings together a series of Cochrane Reviews addressing COPD, aligned with the theme of World COPD Day 2019: ‘All together to end COPD’. The reviews have been selected to address COPD care...November 19 2019
The Airways team is delighted to introduce some new additions to our Editorial Board. Editors comment on most protocols and the interpretation and methods in most reviews. Our new Associate Editors are:Hayley Barnes, Alfred Hospital, Melbourne, AustraliaHayley is a respiratory physician based in Melbourne, Australia, and she specialises in...November 15 2019
Cochrane Airways es un grupo que trabaja en todo el mundo para publicar revisiones sistemáticas Cochrane sobre la prevención y el tratamiento de enfermedades respiratorias (pulmonares). Estos incluyen asma, EPOC (enfermedad pulmonar obstructiva crónica), apnea obstructiva del sueño, bronquiectasia, enfermedad pulmonar intersticial, fibrosis...August 28 2019